WO2016092499A1 - An improved process for the production of quaternary pyridinium salts - Google Patents
An improved process for the production of quaternary pyridinium salts Download PDFInfo
- Publication number
- WO2016092499A1 WO2016092499A1 PCT/IB2015/059507 IB2015059507W WO2016092499A1 WO 2016092499 A1 WO2016092499 A1 WO 2016092499A1 IB 2015059507 W IB2015059507 W IB 2015059507W WO 2016092499 A1 WO2016092499 A1 WO 2016092499A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- acid
- group
- catalyst
- quaternary pyridinium
- Prior art date
Links
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title claims abstract description 70
- 238000000034 method Methods 0.000 title claims abstract description 53
- 238000004519 manufacturing process Methods 0.000 title claims description 16
- 150000004677 hydrates Chemical class 0.000 claims abstract description 24
- 239000000203 mixture Substances 0.000 claims description 25
- 239000003054 catalyst Substances 0.000 claims description 23
- -1 pyridine compound Chemical class 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 20
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 18
- NFCRBQADEGXVDL-UHFFFAOYSA-M cetylpyridinium chloride monohydrate Chemical compound O.[Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NFCRBQADEGXVDL-UHFFFAOYSA-M 0.000 claims description 16
- 239000002904 solvent Substances 0.000 claims description 15
- 229960001927 cetylpyridinium chloride Drugs 0.000 claims description 14
- 150000001412 amines Chemical class 0.000 claims description 12
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 11
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 10
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- 239000003242 anti bacterial agent Substances 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- 150000001350 alkyl halides Chemical class 0.000 claims description 7
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 6
- 239000002738 chelating agent Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 5
- 239000002537 cosmetic Substances 0.000 claims description 5
- 235000019253 formic acid Nutrition 0.000 claims description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- XCVNDBIXFPGMIW-UHFFFAOYSA-N n-ethylpropan-1-amine Chemical compound CCCNCC XCVNDBIXFPGMIW-UHFFFAOYSA-N 0.000 claims description 4
- 239000007858 starting material Substances 0.000 claims description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 4
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 claims description 3
- 239000005711 Benzoic acid Substances 0.000 claims description 3
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 claims description 3
- 230000002882 anti-plaque Effects 0.000 claims description 3
- 235000010233 benzoic acid Nutrition 0.000 claims description 3
- 239000003093 cationic surfactant Substances 0.000 claims description 3
- 235000015218 chewing gum Nutrition 0.000 claims description 3
- 239000012459 cleaning agent Substances 0.000 claims description 3
- 238000005260 corrosion Methods 0.000 claims description 3
- 230000007797 corrosion Effects 0.000 claims description 3
- 239000003599 detergent Substances 0.000 claims description 3
- WQABCVAJNWAXTE-UHFFFAOYSA-N dimercaprol Chemical compound OCC(S)CS WQABCVAJNWAXTE-UHFFFAOYSA-N 0.000 claims description 3
- 239000003344 environmental pollutant Substances 0.000 claims description 3
- 229910001385 heavy metal Inorganic materials 0.000 claims description 3
- 239000003112 inhibitor Substances 0.000 claims description 3
- 239000002324 mouth wash Substances 0.000 claims description 3
- 229940051866 mouthwash Drugs 0.000 claims description 3
- RIVIDPPYRINTTH-UHFFFAOYSA-N n-ethylpropan-2-amine Chemical compound CCNC(C)C RIVIDPPYRINTTH-UHFFFAOYSA-N 0.000 claims description 3
- 239000002086 nanomaterial Substances 0.000 claims description 3
- 235000006408 oxalic acid Nutrition 0.000 claims description 3
- 229960003330 pentetic acid Drugs 0.000 claims description 3
- 230000003239 periodontal effect Effects 0.000 claims description 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 3
- 229940127557 pharmaceutical product Drugs 0.000 claims description 3
- 239000003444 phase transfer catalyst Substances 0.000 claims description 3
- 231100000719 pollutant Toxicity 0.000 claims description 3
- 244000144977 poultry Species 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 3
- 239000000606 toothpaste Substances 0.000 claims description 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 2
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 claims description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 2
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 claims description 2
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical class ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 claims description 2
- 235000011054 acetic acid Nutrition 0.000 claims description 2
- 125000001246 bromo group Chemical group Br* 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 239000000645 desinfectant Substances 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001153 fluoro group Chemical group F* 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 235000011167 hydrochloric acid Nutrition 0.000 claims description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 2
- 125000002346 iodo group Chemical group I* 0.000 claims description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 229960002715 nicotine Drugs 0.000 claims description 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 229940044551 receptor antagonist Drugs 0.000 claims description 2
- 239000002464 receptor antagonist Substances 0.000 claims description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 229940034610 toothpaste Drugs 0.000 claims description 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims 1
- 229960001231 choline Drugs 0.000 claims 1
- 239000002329 esterase inhibitor Substances 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- CLWAXFZCVYJLLM-UHFFFAOYSA-N 1-chlorohexadecane Chemical compound CCCCCCCCCCCCCCCCCl CLWAXFZCVYJLLM-UHFFFAOYSA-N 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- 238000004949 mass spectrometry Methods 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- FKNQCJSGGFJEIZ-UHFFFAOYSA-N 4-methylpyridine Chemical compound CC1=CC=NC=C1 FKNQCJSGGFJEIZ-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 3
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 239000013256 coordination polymer Substances 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 2
- ITQTTZVARXURQS-UHFFFAOYSA-N 3-methylpyridine Chemical compound CC1=CC=CN=C1 ITQTTZVARXURQS-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 239000000544 cholinesterase inhibitor Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- BHIWKHZACMWKOJ-UHFFFAOYSA-N methyl isobutyrate Chemical compound COC(=O)C(C)C BHIWKHZACMWKOJ-UHFFFAOYSA-N 0.000 description 2
- 238000005580 one pot reaction Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- QIVUCLWGARAQIO-OLIXTKCUSA-N (3s)-n-[(3s,5s,6r)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1h-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide Chemical compound C1([C@H]2[C@H](N(C(=O)[C@@H](NC(=O)C=3C=C4C[C@]5(CC4=NC=3)C3=CC=CN=C3NC5=O)C2)CC(F)(F)F)C)=C(F)C=CC(F)=C1F QIVUCLWGARAQIO-OLIXTKCUSA-N 0.000 description 1
- ZRJZXOPARPQRFI-UHFFFAOYSA-M 1-(4-methylhexadecyl)pyridin-1-ium iodide Chemical compound [I-].CC(CCC[N+]1=CC=CC=C1)CCCCCCCCCCCC ZRJZXOPARPQRFI-UHFFFAOYSA-M 0.000 description 1
- YAYNEUUHHLGGAH-UHFFFAOYSA-N 1-chlorododecane Chemical compound CCCCCCCCCCCCCl YAYNEUUHHLGGAH-UHFFFAOYSA-N 0.000 description 1
- GKQHIYSTBXDYNQ-UHFFFAOYSA-M 1-dodecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+]1=CC=CC=C1 GKQHIYSTBXDYNQ-UHFFFAOYSA-M 0.000 description 1
- KMWHQYDMBYABKL-UHFFFAOYSA-N 1-iodohexadecane Chemical compound CCCCCCCCCCCCCCCCI KMWHQYDMBYABKL-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229940123859 Nicotinic receptor antagonist Drugs 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- WDENQIQQYWYTPO-IBGZPJMESA-N acalabrutinib Chemical compound CC#CC(=O)N1CCC[C@H]1C1=NC(C=2C=CC(=CC=2)C(=O)NC=2N=CC=CC=2)=C2N1C=CN=C2N WDENQIQQYWYTPO-IBGZPJMESA-N 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229960004830 cetylpyridinium Drugs 0.000 description 1
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical compound CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 229960001051 dimercaprol Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003673 groundwater Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- WDAXFOBOLVPGLV-UHFFFAOYSA-N isobutyric acid ethyl ester Natural products CCOC(=O)C(C)C WDAXFOBOLVPGLV-UHFFFAOYSA-N 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 1
- JZRYQZJSTWVBBD-UHFFFAOYSA-N pentaporphyrin i Chemical compound N1C(C=C2NC(=CC3=NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 JZRYQZJSTWVBBD-UHFFFAOYSA-N 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229940090181 propyl acetate Drugs 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
Definitions
- This invention in general, relates to an improved process for the production of quaternary ammonium compounds. More particularly, the present invention provides an improved one pot, cost effective and eco-friendly process for large scale industrial production of quaternary pyridinium salts of formula (I) and their hydrates with high yield and purity.
- Quaternary ammonium salts have been remarkably important as starting materials for medicines and quasi-drugs and cosmetics, phase-transfer catalysts, ionized solvents etc.
- quaternary pyridinium salts have been found to be useful mainly as an antibacterial agent thereby indicating an increase in their demand.
- Pyridinium salts (C 12 and C 16 ) are used as solubilizers for water insoluble compounds in analytical chemistry.
- a compound with a C 16 side chain on the pyridinium ring (cetylpyridinium, CP) is being used for the protection of the poultry and medical devices against bacterial contamination. They are also used as antibacterial agent in mouth wash and toothpastes.
- CP is being used in chewing gums as anti-plaque agents, in the dentistry as periodontal agent and in ophthalmic products as preservative.
- the surface activity of CP predicted its ability to form the micelles which is being used for the removal of the pollutants (e.g. arsenic, perchlorate) from the ground water and also for the removal of the heavy metals from solutions.
- Pyridinium detergents are being used as carriers for improving adsorption of the oligonucleotides at the phospholipid membrane.
- Pyridinium salts are also used as cationic surfactant in ink, toner and nano materials, corrosion inhibitors and hard surface cleaning agents.
- the pyridinium analogues with the alkyl chains longer than Cio are known as nicotinic receptor antagonists.
- Pyridinium salts bearing shorter alkyl chains are useful as cholinesterase inhibitors.
- Polish Patent No. PL 149740 discloses a method for the purification of cetylpyridinium chloride (CPC).
- CPC cetylpyridinium chloride
- the process involves condensation of cetyl chloride with dehydrated and purified pyridine at 110 °C for 80 hours.
- the purification of CPC obtained involves dissolving the crude CPC into ethanol, charcoalizing for about 4-6 hours, cooling and left to settle for 12 hours.
- the solution obtained is filtered and greenish yellow CPC obtained is extracted with acetone, filtered and dried to get pure product. Long reaction times along with tedious purification steps make this method commercially unviable.
- EP Patent No. 1125927 discloses a method for the preparation of cetylpyridinium chloride monohydrate. The process involves reacting cetyl chloride (0.44 mole) with 1.8 mole of pyridine under nitrogen atmosphere in an autoclave at 2kg/cm of pressure followed by agitation at 180 °C. The product is crystallized with methyl ethyl ketone to obtain powdery crystal of CPC which was treated with water to obtain CPC monohydrate.
- US Patent No. 5041664 discloses a continuous process for preparing dimethylcocoalkylbenzylammonium chloride which comprises reacting benzyl amine with dimethylcocoalkylamine, over alumina in the presence of isopropanol at a temperature of 120 °C and at a pressure of 1000 psi. High temperature and pressure reaction conditions make the process commercially unviable.
- Marek et al in Molecules, 2010, 15, 1967 reported the preparation of pyridinium salts differing in the alkyl chains (C 8 to C 2 o) by refluxing a mixture of pyridine and alkyl halide in dry ethanol for 40 hours. The solution is evaporated under reduced pressure and the crude oily product crystallized from ether. Satisfactory purity is obtained after several crystallizations from ether suspensions. The compounds with C 18 to C 2 o alkyl chains are contaminated with starting material and hence crystallized from acetone.
- Chinese Patent Application No. CN 103539727A discloses preparation of CPC via condensation of cetyl chloride and pyridine at 100-125 °C for 10-14 hours. After completion of the reaction, pyridine is recycled via depressurization, and an alcohol solvent and active carbon are added for decolourization to obtain crude CPC which is subjected to two purifications. The first purification is done with a mixture of acetone and water followed with the second purification with a mixture of alcohol and water. Thus, this process is cumbersome as involve several steps. Thus, the processes disclosed in the prior art involve multiple steps for purification which results in increase in number of operations and reduced yield, consequently making the process costly and uneconomical.
- Formula (II) Formula (III) ii) optionally, converting the quaternary pyridinium salt of formula (I) to its hydrate, wherein,
- R represents a hydrogen atom, an optionally substituted C 1 -C5 alkyl group or an optionally substituted C 1 -C5 alkoxyl group.
- R can be a hydrogen atom, a straight chain or branched C 1 -C5 alkyl, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t-butyl, n-pentyl, isopentyl, sec-pentyl, tert-pentyl, and the likes; a hydroxy C 1 -C5 alkyl, such as hydroxymethyl, 1-hydroxyethyl, 2-hydroxyethyl, 1-hydroxypropyl, 2-hydroxypropyl, 3-hydroxypropyl, 1-hydroxyisopropyl, 1-hydroxybutyl, 2-hydroxybutyl, 3-hydroxybutyl and the likes; an optionally-substituted C 1 -C5 alkoxyl, such as methoxy, ethoxy, propoxy, trifluoromethoxy and the likes; R' is selected from Ci 2 -C 2 o
- n is any integer from 11-19;
- X is halogen selected from chloro, bromo, fluoro and iodo.
- a large scale industrial process for producing quaternary pyridinium salts of formula (I) and hydrates thereof comprises reacting pyridine compound of formula (II) with alkyl halide of formula (III) in the presence of catalyst, wherein the catalyst is selected from the group consisting of acid, amine and their salts, chelating agent, and mixtures thereof.
- the present invention in general, relates to a large scale industrial process for producing quaternary pyridinium salts and hydrates thereof. More particularly, the present invention provides a cost effective, eco-friendly and less capital intensive large scale industrial process for producing quaternary pyridinium salts and hydrates thereof with high yield and purity.
- the present invention involves a large scale industrial process for producing quaternary pyridinium salts and hydrates thereof, which is easy to operate, involving less operational steps and minimum effluent load generation thereby making the process commercially viable.
- the process for the production of quaternary pyridinium salts of formula (I) and hydrates thereof comprises of reacting pyridine compound of formula (II) with alkyl halide of formula (III) in the presence of a catalyst to form quaternary pyridinium salt of formula (I) and optionally, converting the quaternary pyridinium salt of formula (I) to its hydrate.
- the process for the production of hydrates of quaternary pyridinium salts of formula (I) is one pot process.
- the catalyst is selected from the group consisting of acid, amine and their salts, chelating agent and/or mixtures thereof.
- the amount of acid, amine, chelating agent can vary in the range of 0-100% by weight of the catalyst.
- the acid used as catalyst in the present invention is selected from the group consisting of organic acid, inorganic acid and mixtures thereof.
- the acid used as catalyst herein is selected from the group consisting of acetic acid, formic acid, oxalic acid, benzoic acid, hydrochloric acid, sulfuric acid, phosphoric acid and mixtures thereof.
- the amine used as catalyst in the present invention is selected from the group consisting of organic amine, inorganic amine, their salts and mixtures thereof.
- the amine used as catalyst herein is selected from the group consisting of N-methyl morphline, isopropyl ethyl amine, propyl ethyl amine, triethylamine, trimethylamine, ethanolamine, chloramines, piperidine, pyridine, their salts and mixtures thereof.
- the chelating agent used as catalyst herein is selected from the group consisting of ethylenediaminetetraacetic acid (EDTA); N,N- bis(carboxymethyl)glycine (NDTA); diethylenetriaminepentaacetic acid (DTPA); nitrilotriacetic (NTA) acid; 2,3-dimercapto-l-propanol (dimercaprol); porphine and mixtures thereof.
- reaction of pyridine compound of formula (II) with alkyl halide of formula (III) is carried out in the temperature range of 0 to 175°C, preferably between 75-150 °C.
- the process is carried out in the absence of solvent.
- the step of converting the quaternary pyridinium salt of formula (I) to its hydrate is carried out optionally in the presence of solvent.
- the solvent used is selected from the group consisting of aliphatic alcohol such as methanol, ethanol, n-proponal, isopropanol, n-butanol, iso-butanol; ketone such as acetone, methyl isobutyl ketone, cyclohexanone, methyl ethyl ketone; ester such as ethyl aceate, propyl acetate, butyl acetate, methyl isobutyrate and mixtures thereof.
- the solvent used in the isolation is recovered and reused.
- Isolation of compound of formula (I) and hydrates thereof can be carried out by the techniques known in the art such as filtration, centrifugation, nutch filtration etc.
- compounds of formula (I) and hydrates prepared by the process of the present invention, as anti-bacterial agent in poultry, anti-plaque agents in chewing gums and dentistry, surfactant in detergents, nicotine receptor antagonists, cholinesterase inhibitors, remover of pollutants, heavy metals, solubilizers for water insoluble compounds in analytical chemistry and starting materials for medicines and quasi drugs and cosmetics.
- Cetyl chloride (100 g), pyridine (250 g) and catalyst (2 g containing the mixture of EDTA, N-methyl morpholine, N,N-bis(carboxymethyl) glycine and phosphoric acid) were charged into a round bottom flask, heated to 90-100 °C and maintained for 6-8 hours. After the completion of reaction, the mass was cooled, filtered and washed with ethyl acetate to get crystalline cetylpyridinium chloride (126.5 g) with 99.5% purity. The product was confirmed by m.p., mass spectroscopy, 1H NMR and 13 C NMR.
- Cetyl chloride (100 g), pyridine (300 g) and catalyst (2 g containing the mixture of isopropyl ethyl amine, N-methyl morpholine, oxalic acid and sulfuric acid) were charged into a round bottom flask, heated to 90-100 °C and maintained for 6-8 hours. After the completion of reaction, the mass was cooled, filtered and the cake was charged to a mixture of methyl isobutyl ketone (200 g) and water (7 g). Mass was agitated to get crystalline cetylpyridinium chloride monohydrate (120 g) with 99.6% purity. The solvent and unreacted pyridine was recovered and reused in next batch. The product was confirmed by m.p., mass spectroscopy, 1H NMR and 13 C NMR.
- Cetyl chloride (10 kg), recovered pyridine (28 kg) and catalyst (0.2 kg containing the mixture of formic acid, propyl ethyl amine, N,N-bis(carboxymethyl) glycine and hydrochloric acid) were charged into a round bottom flask, heated to 90-100 °C and maintained for 6-8 hours. After the completion of reaction, the mass was cooled, filtered and the product obtained was washed with recovered methyl isobutyl ketone to get crystalline cetylpyridinium chloride (12.6 kg) with 99.5% purity. The product was confirmed by m.p., mass spectroscopy, 1H NMR and 13 C NMR.
- Cetyl chloride (100 g), 2-methylpyridine (250 g) and catalyst (2.0 g containing the mixture of triethylamine, EDTA, benzoic acid, sulfuric acid and formic acid) were charged into a round bottom flask, heated to 120-135 °C and maintained for 25-30 hours. After the completion of reaction, the mass was cooled, filtered and the product obtained was washed with ethyl acetate to get crystalline l-hexadecyl-2-methyl pyridinium chloride (120 g) with 99.2% purity. The product was confirmed by mass spectroscopy, 1 H NMR and 13 C NMR.
- Cetyl chloride (100 g), 3-methyl pyridine (250 g) and catalyst (2.0 g containing the mixture of formic acid, propyl ethyl amine, N,N-bis(carboxymethyl)glycine and hydrochloric acid) were charged into a round bottom flask, heated to 130-140 °C and maintained for 15-16 hours. After the completion of reaction, the mass was cooled, filtered and the product obtained was washed with ethyl acetate to get crystalline l-hexadecyl-3 -methyl pyridinium chloride (122 g) with 99.8% purity. The product was confirmed by mass spectroscopy, 1H NMR and 13 C NMR.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
Abstract
Disclosed herein is cost effective and eco-friendly process for producing quaternary pyridinium salts and their hydrates thereof, with high yield and purity at industrial scale.
Description
AN IMPROVED PROCESS FOR THE PRODUCTION OF QUATERNARY
PYRIDINIUM SALTS
Field of the Invention
This invention, in general, relates to an improved process for the production of quaternary ammonium compounds. More particularly, the present invention provides an improved one pot, cost effective and eco-friendly process for large scale industrial production of quaternary pyridinium salts of formula (I) and their hydrates with high yield and purity.
Background of the Invention
Quaternary ammonium salts have been remarkably important as starting materials for medicines and quasi-drugs and cosmetics, phase-transfer catalysts, ionized solvents etc. Among the salts, quaternary pyridinium salts have been found to be useful mainly as an antibacterial agent thereby indicating an increase in their demand.
Pyridinium salts (C12 and C16) are used as solubilizers for water insoluble compounds in analytical chemistry. A compound with a C16 side chain on the pyridinium ring (cetylpyridinium, CP) is being used for the protection of the poultry and medical devices against bacterial contamination. They are also used as antibacterial agent in mouth wash and toothpastes. CP is being used in chewing gums as anti-plaque agents, in the dentistry as periodontal agent and in ophthalmic products as preservative. The surface activity of CP predicted its ability to form the micelles which is being used for the removal of the pollutants (e.g. arsenic, perchlorate) from the ground water and also for the removal of the heavy metals from solutions. It is also being used as surface stabilizer in pharmaceutical products. Pyridinium detergents are being used as carriers for improving adsorption of the oligonucleotides at the phospholipid membrane. Pyridinium salts are also used as cationic surfactant in ink, toner and nano materials, corrosion inhibitors and hard surface cleaning agents. The pyridinium analogues with the alkyl chains longer than Cio are known as nicotinic receptor antagonists. Pyridinium salts bearing shorter alkyl chains are useful as cholinesterase inhibitors.
In the prior art various methods are reported for the preparation of quaternary pyridinium salts. Knight et al in J. Chem. Soc, 1938, 682 reported a method for preparing dodecyl
pyridinium chloride by reacting dodecyl chloride with pyridine at 100 °C for 24 hours, but the yield is very low 1.7%.
Shelton et al in J. Am. Chem. Soc, 1946, 68, 757 reported a method involving the reaction of an alkyl halide with 10 to 30% excess amount of pyridine at temperatures from 60 to 130 °C for 8 to 16 hours to afford 95% quaternary pyridinium salt. In this method rate of reaction is increased by using the excess of amine. Also for getting pure product one or two crystallization are done after the completion of reaction.
Barni et al in J. Het. Chem., 1986, 23, 209 reported the reaction of 4-methyl pyridine with cetyl iodide under refluxing for 6 hours to obtain 4-methyl cetylpyridinium iodide with 75% yield.
Polish Patent No. PL 149740 discloses a method for the purification of cetylpyridinium chloride (CPC). The process involves condensation of cetyl chloride with dehydrated and purified pyridine at 110 °C for 80 hours. The purification of CPC obtained involves dissolving the crude CPC into ethanol, charcoalizing for about 4-6 hours, cooling and left to settle for 12 hours. The solution obtained is filtered and greenish yellow CPC obtained is extracted with acetone, filtered and dried to get pure product. Long reaction times along with tedious purification steps make this method commercially unviable.
EP Patent No. 1125927 discloses a method for the preparation of cetylpyridinium chloride monohydrate. The process involves reacting cetyl chloride (0.44 mole) with 1.8 mole of pyridine under nitrogen atmosphere in an autoclave at 2kg/cm of pressure followed by agitation at 180 °C. The product is crystallized with methyl ethyl ketone to obtain powdery crystal of CPC which was treated with water to obtain CPC monohydrate.
US Patent No. 5041664 discloses a continuous process for preparing dimethylcocoalkylbenzylammonium chloride which comprises reacting benzyl amine with dimethylcocoalkylamine, over alumina in the presence of isopropanol at a temperature of 120 °C and at a pressure of 1000 psi. High temperature and pressure reaction conditions make the process commercially unviable.
Marek et al in Molecules, 2010, 15, 1967 reported the preparation of pyridinium salts differing in the alkyl chains (C8 to C2o) by refluxing a mixture of pyridine and alkyl halide in dry ethanol for 40 hours. The solution is evaporated under reduced pressure and the crude oily product crystallized from ether. Satisfactory purity is obtained after several
crystallizations from ether suspensions. The compounds with C18 to C2o alkyl chains are contaminated with starting material and hence crystallized from acetone.
Chinese Patent Application No. CN 103539727A discloses preparation of CPC via condensation of cetyl chloride and pyridine at 100-125 °C for 10-14 hours. After completion of the reaction, pyridine is recycled via depressurization, and an alcohol solvent and active carbon are added for decolourization to obtain crude CPC which is subjected to two purifications. The first purification is done with a mixture of acetone and water followed with the second purification with a mixture of alcohol and water. Thus, this process is cumbersome as involve several steps. Thus, the processes disclosed in the prior art involve multiple steps for purification which results in increase in number of operations and reduced yield, consequently making the process costly and uneconomical. Further, the processes disclosed in the prior art can be used for producing small batches of the desired products in low yield, hence making the processes unsuitable for large-scale production. In view of the increasing demand for producing quaternary pyridinium salts and hydrates thereof, of high yield and purity, it is therefore desirable to develop a commercially and economically viable process for industrial manufacturing of quaternary pyridinium salts and hydrates thereof with high yield and purity which can address the above mentioned problems associated with the known processes. Summary of the Invention
It is a principal object of the present invention to provide a process for producing quaternary pyridinium salts and hydrates thereof at industrial scale, wherein the process enables single pot production of the compounds.
It is another object of the invention to provide a cost effective and commercially viable process for producing quaternary pyridinium salts and hydrates thereof at industrial scale, wherein the process provides product with desired purity, involving simple isolation steps, avoiding multi stage operations for purification.
It is another object of the present invention to provide an eco-friendly and carbon efficient process for producing quaternary pyridinium salts and hydrates thereof at industrial scale,
wherein the process enables production of highly pure quaternary pyridinium salts at industrial scale with minimum generation of effluents.
In accordance with object of the present invention, there is provided a large scale industrial process for the production of quaternary pyridinium salts of formula (I) and hydrates thereof, wherein the process comprises:
Formula (I) reacting pyridine compound of formula (II) with alkyl halide of formula (III) presence of a catalyst to obtain quaternary pyridinium salt of formula (I),
Formula (II) Formula (III) ii) optionally, converting the quaternary pyridinium salt of formula (I) to its hydrate, wherein,
R represents a hydrogen atom, an optionally substituted C1-C5 alkyl group or an optionally substituted C1-C5 alkoxyl group.
More specifically, R can be a hydrogen atom, a straight chain or branched C1-C5 alkyl, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t-butyl, n-pentyl, isopentyl, sec-pentyl, tert-pentyl, and the likes; a hydroxy C1-C5 alkyl, such as hydroxymethyl, 1-hydroxyethyl, 2-hydroxyethyl, 1-hydroxypropyl, 2-hydroxypropyl, 3-hydroxypropyl, 1-hydroxyisopropyl, 1-hydroxybutyl, 2-hydroxybutyl, 3-hydroxybutyl and the likes; an optionally-substituted C1-C5 alkoxyl, such as methoxy, ethoxy, propoxy, trifluoromethoxy and the likes;
R' is selected from Ci2-C2o alkyl group;
n is any integer from 11-19;
X is halogen selected from chloro, bromo, fluoro and iodo.
In accordance with another object of the present invention, there is provided a large scale industrial process for producing quaternary pyridinium salts of formula (I) and hydrates thereof, wherein the process comprises reacting pyridine compound of formula (II) with alkyl halide of formula (III) in the presence of catalyst, wherein the catalyst is selected from the group consisting of acid, amine and their salts, chelating agent, and mixtures thereof.
In accordance with yet another object of the present invention there is provided a large scale industrial process for producing quaternary pyridinium salts of formula (I) and hydrates thereof, wherein the reaction is performed in the temperature range of 0 - 175 °C.
Detailed Description of the Invention
While this specification concludes with claims particularly pointing out and distinctly claiming that, which is regarded as the invention, it is anticipated that the invention can be more readily understood through reading the following detailed description of the invention and study of the included examples.
The present invention, in general, relates to a large scale industrial process for producing quaternary pyridinium salts and hydrates thereof. More particularly, the present invention provides a cost effective, eco-friendly and less capital intensive large scale industrial process for producing quaternary pyridinium salts and hydrates thereof with high yield and purity.
The present invention involves a large scale industrial process for producing quaternary pyridinium salts and hydrates thereof, which is easy to operate, involving less operational steps and minimum effluent load generation thereby making the process commercially viable.
It has been observed during the preparation of quaternary pyridinium salts and hydrates of the present invention that for reducing reaction time, if the temperature of the reaction is increased then the color of the product deviates from white. Alternatively, if the temperature is reduced then the rate of reaction becomes slow thereby resulting in incomplete reaction. However, by using the catalyst of the present invention, the temperature required for condensation of pyridine compounds with alky halide is reduced and conversion is also complete resulting in the formation of product with desired purity.
According to the present invention, the process for the production of quaternary pyridinium salts of formula (I) and hydrates thereof, comprises of reacting pyridine compound of formula (II) with alkyl halide of formula (III) in the presence of a catalyst to form quaternary pyridinium salt of formula (I) and optionally, converting the quaternary pyridinium salt of formula (I) to its hydrate.
Formula (I) Formula (II) Formula (III) wherein R, R', n and X are the same as defined earlier.
According to the present invention, the process for the production of hydrates of quaternary pyridinium salts of formula (I) is one pot process.
According to the present invention, the catalyst is selected from the group consisting of acid, amine and their salts, chelating agent and/or mixtures thereof. The amount of acid, amine, chelating agent can vary in the range of 0-100% by weight of the catalyst.
The acid used as catalyst in the present invention, is selected from the group consisting of organic acid, inorganic acid and mixtures thereof. The acid used as catalyst herein is selected from the group consisting of acetic acid, formic acid, oxalic acid, benzoic acid, hydrochloric acid, sulfuric acid, phosphoric acid and mixtures thereof.
The amine used as catalyst in the present invention, is selected from the group consisting of organic amine, inorganic amine, their salts and mixtures thereof. The amine used as catalyst herein is selected from the group consisting of N-methyl morphline, isopropyl ethyl amine, propyl ethyl amine, triethylamine, trimethylamine, ethanolamine, chloramines, piperidine, pyridine, their salts and mixtures thereof.
According to the present invention, the chelating agent used as catalyst herein is selected from the group consisting of ethylenediaminetetraacetic acid (EDTA); N,N- bis(carboxymethyl)glycine (NDTA); diethylenetriaminepentaacetic acid (DTPA);
nitrilotriacetic (NTA) acid; 2,3-dimercapto-l-propanol (dimercaprol); porphine and mixtures thereof.
According to the present invention, the reaction of pyridine compound of formula (II) with alkyl halide of formula (III) is carried out in the temperature range of 0 to 175°C, preferably between 75-150 °C. The process is carried out in the absence of solvent.
According to the present invention, the step of converting the quaternary pyridinium salt of formula (I) to its hydrate is carried out optionally in the presence of solvent. The solvent used is selected from the group consisting of aliphatic alcohol such as methanol, ethanol, n-proponal, isopropanol, n-butanol, iso-butanol; ketone such as acetone, methyl isobutyl ketone, cyclohexanone, methyl ethyl ketone; ester such as ethyl aceate, propyl acetate, butyl acetate, methyl isobutyrate and mixtures thereof.
According to the present invention, the solvent used in the isolation is recovered and reused. Isolation of compound of formula (I) and hydrates thereof, can be carried out by the techniques known in the art such as filtration, centrifugation, nutch filtration etc. According to the present invention, there is provided use of compounds of formula (I) and hydrates, prepared by the process of the present invention, as antibacterial agent, phase transfer catalyst, ionized solvents, solubilizers, in cosmetics and pharmaceuticals.
According to another embodiment of the present invention, there is provided use of compounds of formula (I) and hydrates, prepared by the process of the present invention, as anti-bacterial agent in poultry, anti-plaque agents in chewing gums and dentistry, surfactant in detergents, nicotine receptor antagonists, cholinesterase inhibitors, remover of pollutants, heavy metals, solubilizers for water insoluble compounds in analytical chemistry and starting materials for medicines and quasi drugs and cosmetics.
According to yet another embodiment aspect of the present invention, there is provided use of compounds of formula (I) and hydrates, prepared by the process of the present invention, as antibacterial agent in mouthwash and toothpaste, periodontal agent in dentistry, cationic surfactant in ink, toner and nano materials, preservative in ophthalmic products, surface stabilizer in pharmaceutical products, disinfectant in medical devices, corrosion inhibitor, and hard surface cleaning agent. The present invention is further illustrated below with reference to the following examples without intending to limit the scope of the invention in any manner.
Example -1
Synthesis of cetylpyridinium chloride
Cetyl chloride (100 g), pyridine (250 g) and catalyst (2 g containing the mixture of EDTA, N-methyl morpholine, N,N-bis(carboxymethyl) glycine and phosphoric acid) were charged into a round bottom flask, heated to 90-100 °C and maintained for 6-8 hours. After the completion of reaction, the mass was cooled, filtered and washed with ethyl acetate to get crystalline cetylpyridinium chloride (126.5 g) with 99.5% purity. The product was confirmed by m.p., mass spectroscopy, 1H NMR and 13C NMR.
Example -2 Synthesis of cetylpyridinium chloride monohydrate
Cetyl chloride (100 g), pyridine (300 g) and catalyst (2 g containing the mixture of isopropyl ethyl amine, N-methyl morpholine, oxalic acid and sulfuric acid) were charged into a round bottom flask, heated to 90-100 °C and maintained for 6-8 hours. After the completion of reaction, the mass was cooled, filtered and the cake was charged to a mixture of methyl isobutyl ketone (200 g) and water (7 g). Mass was agitated to get crystalline cetylpyridinium chloride monohydrate (120 g) with 99.6% purity. The solvent and unreacted pyridine was recovered and reused in next batch. The product was confirmed by m.p., mass spectroscopy, 1H NMR and 13C NMR.
Example -3 Synthesis of cetylpyridinium chloride
Cetyl chloride (10 kg), recovered pyridine (28 kg) and catalyst (0.2 kg containing the mixture of formic acid, propyl ethyl amine, N,N-bis(carboxymethyl) glycine and hydrochloric acid) were charged into a round bottom flask, heated to 90-100 °C and maintained for 6-8 hours. After the completion of reaction, the mass was cooled, filtered and the product obtained was washed with recovered methyl isobutyl ketone to get crystalline cetylpyridinium chloride (12.6 kg) with 99.5% purity. The product was confirmed by m.p., mass spectroscopy, 1H NMR and 13C NMR.
Example -4
Synthesis of l-hexadecyl-2-methyl pyridinium chloride
Cetyl chloride (100 g), 2-methylpyridine (250 g) and catalyst (2.0 g containing the mixture of triethylamine, EDTA, benzoic acid, sulfuric acid and formic acid) were charged into a round bottom flask, heated to 120-135 °C and maintained for 25-30 hours. After the completion of reaction, the mass was cooled, filtered and the product obtained was washed with ethyl acetate to get crystalline l-hexadecyl-2-methyl pyridinium chloride (120 g) with 99.2% purity. The product was confirmed by mass spectroscopy, 1 H NMR and 13 C NMR.
Example -5 Synthesis of l-hexadecyl-3-methyl pyridinium chloride
Cetyl chloride (100 g), 3-methyl pyridine (250 g) and catalyst (2.0 g containing the mixture of formic acid, propyl ethyl amine, N,N-bis(carboxymethyl)glycine and hydrochloric acid) were charged into a round bottom flask, heated to 130-140 °C and maintained for 15-16 hours. After the completion of reaction, the mass was cooled, filtered and the product obtained was washed with ethyl acetate to get crystalline l-hexadecyl-3 -methyl pyridinium chloride (122 g) with 99.8% purity. The product was confirmed by mass spectroscopy, 1H NMR and 13C NMR.
Example -6
Synthesis of l-hexadecyl-4-methyl pyridinium chloride Cetyl chloride (100 g), 4-methyl pyridine (250 g) and catalyst (2.0 g containing the mixture of EDTA, N-methyl morpholine, N,N-bis(carboxymethyl)glycine and phosphoric acid) were charged into a round bottom flask, heated to 135-145 °C and maintained for 8-10 hours. After the completion of reaction, the mass was cooled, filtered and the product obtained was washed with ethyl acetate to get crystalline l-hexadecyl-4-methyl pyridinium chloride (118g) with 99.0% purity. The product was confirmed by mass spectroscopy, 1H NMR and 13C NMR.
Claims
1. A process for the production of quaternary pyridinium salts of formula (I) and hydrates thereof, wherein the process comprises:
Formula (I) reacting pyridine compound of formula (II) with alkyl halide of formula (III) presence of a catalyst to form quaternary pyridinium salt of formula (I),
Formula (II) Formula (III) ii) optionally, converting the quaternary pyridinium salt of formula (I) to its hydrate, wherein,
R represents a hydrogen atom, an optionally substituted Q-C5 alkyl group or an optionally substituted C1-C5 alkoxyl group.
More specifically, R can be a hydrogen atom, a straight chain or branched C1-C5 alkyl, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t-butyl, n-pentyl, isopentyl, sec-pentyl, tert-pentyl, and the likes; a hydroxy C1-C5 alkyl, such as hydroxymethyl, 1-hydroxyethyl, 2-hydroxyethyl, 1-hydroxypropyl, 2-hydroxypropyl, 3-hydroxypropyl, 1-hydroxyisopropyl, 1 -hydroxybutyl, 2- hydroxybutyl, 3-hydroxybutyl and the likes; an optionally-substituted C1-C5 alkoxyl, such as methoxy, ethoxy, propoxy, trifluoromethoxy and the likes;
R' is selected from C12-C20 alkyl group
n is any integer from 11-19
X is halogen atom selected from chloro, bromo, fluoro and iodo group.
2. The process as claimed in claim 1, wherein the catalyst is selected from the group consisting of acid, amine and their salts, chelating agent and/or mixtures thereof.
3. The process as claimed in claim 2, wherein the catalyst is selected from the group consisting of organic acid, inorganic acid and mixtures thereof.
4. The process as claimed in claim 1 and 2, wherein the catalyst is selected from the group consisting of acetic acid, formic acid, oxalic acid, benzoic acid, hydrochloric acid, sulfuric acid, phosphoric acid and mixtures thereof.
5. The process as claimed in claim 2, wherein the catalyst is selected from the group consisting of organic amine, inorganic amine, their salts and mixtures thereof.
6. The process as claimed in claim 1 and 2, wherein the amine is selected from the group consisting of N-methyl morphline, ethylisopropyl amine, propylethyl amine, triethylamine, trimethylamine, ethanolamine, chloramines, piperidine, pyridine, their salts and mixtures thereof.
7. The process as claimed in claim 1 and 2, wherein the chelating agent is selected from the group consisting of ethylenediaminetetraacetic acid; N,N-bis(carboxymethyl)glycine, diethylenetriaminepentaacetic acid, nitrilotriacetic acid, 2,3-dimercapto-l-propanol and mixtures thereof.
8. The process as claimed in claim 1, wherein the reaction is carried out in the temperature range of 0-175 °C.
9. The process as claimed in claim 8, wherein the reaction is carried out in the temperature range of 75-150 °C.
10. The process as claimed in claim 1, wherein the step (ii) is carried out optionally in the presence of solvent selected from the group consisting of aliphatic alcohol, ketone, ester and mixtures thereof.
1. The process as claimed in claim 1, wherein the compound of formula (I) is cetylpyridinium chloride and its hydrate.
The quaternary pyridinium salts of formula (I) and hydrates, prepared by the process as claimed in any of the claims 1 to 11, as and when used as antibacterial agent, phase transfer catalyst, ionized solvents, solubilizers, in cosmetics and pharmaceuticals.
The quaternary pyridinium salts of formula (I) and hydrates, prepared by the process as claimed in any of the claims 1 to 11, as and when used as anti-bacterial agent in poultry, anti-plaque agents in chewing gums and dentistry, surfactant in detergents, nicotine receptor antagonists, choline esterase inhibitors, remover of pollutants, heavy metals, solubilizers for water insoluble compounds in analytical chemistry and starting materials for medicines and quasi drugs and cosmetics.
The quaternary pyridinium salts of formula (I) and hydrates, prepared by the process as claimed in any of the claims 1 to 11, as and when used as antibacterial agent in mouthwash and toothpaste, periodontal agent in dentistry, cationic surfactant in ink, toner and nano materials, preservative in ophthalmic products, surface stabilizer in pharmaceutical products, disinfectant in medical devices, corrosion inhibitor, and hard surface cleaning agent.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3661DE2014 | 2014-12-12 | ||
IN3661/DEL/2014 | 2014-12-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016092499A1 true WO2016092499A1 (en) | 2016-06-16 |
Family
ID=56106814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2015/059507 WO2016092499A1 (en) | 2014-12-12 | 2015-12-10 | An improved process for the production of quaternary pyridinium salts |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2016092499A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116283751A (en) * | 2023-03-17 | 2023-06-23 | 胜利油田物华化工厂 | Bactericide for sewage treatment and synthetic method |
US12247246B2 (en) | 2017-09-26 | 2025-03-11 | Washington University | Identification of inhibitors of TcpC and TIR NADase activity |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5110929A (en) * | 1986-08-07 | 1992-05-05 | Medice Cham.-Pharm. Fabrik Putter Gmbh & Co. Kg | Process for the preparation of N-alkylated quaternary nitrogen containing aromatic heterocycles |
US20010018526A1 (en) * | 2000-02-14 | 2001-08-30 | Wako Pure Chemical Industries, Ltd. | Method for preparation of a quaternary ammonium salt |
WO2005072693A1 (en) * | 2004-01-29 | 2005-08-11 | The Procter & Gamble Company | Oral care compositions comprising increased bioavailable levels of quaternary ammonium antimicrobials |
-
2015
- 2015-12-10 WO PCT/IB2015/059507 patent/WO2016092499A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5110929A (en) * | 1986-08-07 | 1992-05-05 | Medice Cham.-Pharm. Fabrik Putter Gmbh & Co. Kg | Process for the preparation of N-alkylated quaternary nitrogen containing aromatic heterocycles |
US20010018526A1 (en) * | 2000-02-14 | 2001-08-30 | Wako Pure Chemical Industries, Ltd. | Method for preparation of a quaternary ammonium salt |
WO2005072693A1 (en) * | 2004-01-29 | 2005-08-11 | The Procter & Gamble Company | Oral care compositions comprising increased bioavailable levels of quaternary ammonium antimicrobials |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12247246B2 (en) | 2017-09-26 | 2025-03-11 | Washington University | Identification of inhibitors of TcpC and TIR NADase activity |
CN116283751A (en) * | 2023-03-17 | 2023-06-23 | 胜利油田物华化工厂 | Bactericide for sewage treatment and synthetic method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102230628B1 (en) | Vortioxetine manufacturing process | |
US8569497B2 (en) | Process for the preparation of piperazine derivatives | |
JP2012515142A5 (en) | ||
AU2008321691A1 (en) | Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts | |
US9663450B2 (en) | Process for the purification of melphalan | |
WO2016092499A1 (en) | An improved process for the production of quaternary pyridinium salts | |
JP5246516B2 (en) | Method for isolating methyl-4-formylbenzoate and dimethyl terephthalate | |
JP4728636B2 (en) | Process for producing optically active amino acids | |
EP4303211B1 (en) | Industrial process for the preparation of hexanoic acid, 6(nitrooxy)-,(1s,2e)-3-[(1r,2r,3s,5r)-2-[(2z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]3,5-dihydroxycyclopentyl]-1-(2-phenyl ethyl)-2-propen-1-yl ester and high pure product | |
JP6787331B2 (en) | Method for producing acid halide solution, mixed solution, and method for producing monoester compound | |
CN112272665B (en) | Process for preparing ritalst | |
JPS6227059B2 (en) | ||
KR100881890B1 (en) | Method for preparing safogrelate hydrochloride | |
JP5419545B2 (en) | Method for producing orthoester compound | |
JP2011093869A (en) | Process for producing optically active 2-phenoxybutanoic acids | |
CN110845410A (en) | Method for preparing 6, 7-dimethoxy-3, 4-dihydroisoquinoline hydrochloride by one-pot method | |
JP4397990B2 (en) | Purification method of 3-alkylflavanonol derivatives | |
JP6219681B2 (en) | Process for preparing fluoroacylated arylamines | |
HU227319B1 (en) | Process for the production of (2-chloro-ethoxy)-acetic acid-n,n-dimethylamide and its intermediate and the novel intermediate | |
JP6809485B2 (en) | Method for producing acid halide solution and method for producing monoester compound | |
JP4493805B2 (en) | Method for producing high-purity benzoic acid derivative | |
EP3458522B1 (en) | Process for the preparation of diaminophenothiazinium compounds having a high degree of purity | |
CN103917515A (en) | 3-Chloro-4-methylbenzoic acid isopropyl ester and its production method | |
WO2006100731A1 (en) | Method for acetylating 5-amino-2,4,6-triiodoisophthalic acid derivative | |
JP4634168B2 (en) | Theanine production method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15866449 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15866449 Country of ref document: EP Kind code of ref document: A1 |